$2.89
-0.09 (-3.02%)
Open$3.04
Previous Close$2.98
Day High$3.32
Day Low$2.85
52W High$19.45
52W Low$2.80
Volume—
Avg Volume430.2K
Market Cap67.11M
P/E Ratio—
EPS$-65.26
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 35.77M | 36.63M | 30.48M |
| Net Income | -8,575,403 | -9,331,208 | -6,103,234 |
| Profit Margin | -24.0% | -25.5% | -20.0% |
| EBITDA | -11,561,063 | -12,252,085 | -10,099,093 |
| Free Cash Flow | -5,624,875 | -5,815,077 | -3,826,455 |
| Rev Growth | +23.1% | +18.9% | +13.6% |
| Debt/Equity | 0.47 | 0.46 | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |